fbpx

Programme

MedCan Summit has been approved for CME by the Royal New Zealand College of General Practitioners and the Pharmaceutical Society of New Zealand. For more information, click here

The programme for the November MedCan Summit is still to be confirmed. We will endeavour to keep the programme as similar as possible to the original MedCan Summit programme, plus we may add new content now that the Medicinal Cannabis Scheme has taken effect.

Due to travel restrictions it may not be possible for all of our international speakers to attend in-person, so arrangements will be made for them to present virtually, if required.

Expand All +
  • Main Summit: Tuesday 10 November 2020


  • Pre-Summit Workshops: Monday 9 November 2020


  • This talk lays the groundwork of the endocannabinoid system (deficiency syndrome), synthetics, phytocannabinoids (plant, cannabinoids CBD vs CB2, terpenes) delivery mechanisms and contraindications
    Medicine/CPD
    Science

  • Understand the history of cannabis and the current issues with regards to the stigma of cannabis.
    Medicine/CPD

  • Dr Arboleda will share current evidence and practical experience in how cannabiniod-based medicines are being use to treat chronic pain and in palliative care management.
    Medicine/CPD

  • Understand the primary business principles required to initiate and grow a successful business within the emerging cannabis industry.
    Industry

  • Understand the development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit.
    Science

  • Hear Dr Washer's perspective on the unexpected journey from biotech to cannabis medicine and back again.
    Industry

  • Lunch

  • Learn about patients perspective on cannabis use, the data collected on effectiveness and adverse effects of medicinal cannabis.
    Science

  • How to use medicinal cannabis in real world practice, including how to use it to treat chronic pain, anxiety, insominia and opioid overuse.
    Medicine/CPD

  • Learn about the options, current industrial practice and future trends for the extraction of cannabis.
    Industry

  • Get an overview of pharmaceutical cannabis including safety, clinical evidence, pharmacology, pharmacokinetics, interactions, contraindications and dosage forms.
    Medicine/CPD

  • Patients will share their experiences of using medicinal cannabis.
    Medicine/CPD
    Industry
    Policy

  • Facilitator & Asia/Pacific - Martin Woodbridge, International Consultant, Woodbridge Research USA/Canada - Brent Zettl, President and CEO, ZYUS Life Sciences Inc. Recent emerging environments - Rhys Cohen, Director, Cannabis Consulting Australia
    Medicine/CPD
    Industry
    NZ Economy
    Policy
    Science
    Technology

  • Meet and discuss with industry along the supply chain seed to sale
    Industry

  • Round table discussions facilitated by experts covering the following topics; Growing, Processing and Manufacturing, Quality, formulation, and Testing & Regulations
    Industry

  • Round table discussions facilitated by experts covering the following topics; Growing, Processing and Manufacturing, Quality, formulation and testing & Regulations
    Industry